Authors
Treatment outcomes for multidrug-resistant (MDR) tuberculosis (TB) are poor with only approximately 50% of patients attaining treatment success [1]. An important driver of treatment failure in many settings is the unavailability of effective drugs for MDR- and extensively drug-resistant (XDR)-TB. Bedaquiline-based therapy leads to high rates of culture conversion in the treatment of MDR-TB
No takes yet. Share an insight, caveat, or question.
Olaru et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: